IRIS
GALATI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.144
NA - Nord America 1.085
EU - Europa 499
SA - Sud America 80
AF - Africa 26
OC - Oceania 6
Totale 5.840
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.367
US - Stati Uniti d'America 1.041
CN - Cina 357
IT - Italia 241
HK - Hong Kong 149
BD - Bangladesh 138
GB - Regno Unito 68
FR - Francia 55
BR - Brasile 51
VN - Vietnam 38
DE - Germania 37
IN - India 25
CA - Canada 19
FI - Finlandia 19
NL - Olanda 17
MX - Messico 16
CZ - Repubblica Ceca 15
PL - Polonia 11
TR - Turchia 11
AR - Argentina 9
ZA - Sudafrica 8
ES - Italia 7
PE - Perù 7
SA - Arabia Saudita 7
CL - Cile 6
IQ - Iraq 6
MY - Malesia 6
UA - Ucraina 6
AU - Australia 5
PK - Pakistan 5
RU - Federazione Russa 5
SE - Svezia 5
EG - Egitto 4
ID - Indonesia 4
KE - Kenya 4
AE - Emirati Arabi Uniti 3
JP - Giappone 3
NP - Nepal 3
PH - Filippine 3
TH - Thailandia 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
GN - Guinea 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 5.840
Salva come PNG Salva come JPEG
Città #
San Jose 323
Singapore 257
Ashburn 193
Rome 151
Hong Kong 146
Beijing 117
Hefei 103
Dallas 73
Boardman 55
London 50
Lauterbourg 42
Shanghai 36
Santa Clara 34
Munich 25
Los Angeles 24
New York 24
Council Bluffs 19
Seattle 17
Brno 15
Ho Chi Minh City 15
San Francisco 14
Mexico City 13
São Paulo 13
Turku 11
Amsterdam 10
Warsaw 10
West Jordan 10
Boston 9
Buffalo 9
Helsinki 8
Naples 8
Washington 8
Toronto 7
Orem 6
Pune 6
Guangzhou 5
Hanoi 5
Johannesburg 5
Las Vegas 5
Manchester 5
Montreal 5
Paris 5
Sona 5
Brooklyn 4
Chennai 4
Lima 4
Milan 4
Nairobi 4
Secaucus 4
Stockholm 4
Bologna 3
Chicago 3
Frankfurt am Main 3
Haiphong 3
Krasnodar 3
Kuala Lumpur 3
Lahore 3
New Orleans 3
Palermo 3
Riyadh 3
Uberlândia 3
Verona 3
Augusta 2
Bangkok 2
Basra 2
Boydton 2
Cagliari 2
Cairo 2
Camden 2
Canberra 2
Caracas 2
Central 2
Charlotte 2
Cosenza 2
Dnipro 2
Florence 2
Genoa 2
Goiânia 2
Hangzhou 2
Hengshui 2
Jeddah 2
Kansas City 2
Kirkuk 2
Manama 2
Manaus 2
Melbourne 2
Modena 2
New Delhi 2
Philadelphia 2
Poplar 2
Portsmouth 2
Suffern 2
Taizhou 2
Tangshan 2
Tokyo 2
Wuxi 2
Zhengzhou 2
Acalanes Ridge 1
Adana 1
Ahmedabad 1
Totale 2.038
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 246
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 240
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 230
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 230
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 225
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 224
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 224
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 223
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 218
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 214
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 211
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 208
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 203
Assessment of liver function by the exhaled breath-print during chronic liver disease 202
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 172
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 169
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 135
Diabetes in chronic liver disease: from old concepts to new evidence 134
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 131
A challenging alfa-fetoprotein in a cirrhotic patient 129
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 118
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 114
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 108
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 103
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 103
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 89
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 70
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 68
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 65
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 64
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 63
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 59
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 56
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 56
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 53
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 53
Hepatic complications of bariatric surgery : the reverse side of the coin 52
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis 50
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 49
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 48
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 48
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 47
GAS EXCHANGE AND PULMONARY MICROCIRCULATION ABNORMALITIES IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC LIVER DISEASE PATIENTS FREE FROM HEPATOPULMONARY SYNDROME 45
Surgical complications after resection of adrenal carcinoma 42
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 41
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 41
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 38
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 38
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 38
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 35
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 35
Totale 5.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 4 0 0 2 0 0 5 0 0 72
2022/202333 6 0 1 1 0 2 9 4 0 1 9 0
2023/2024194 8 13 6 20 13 79 2 13 3 12 7 18
2024/20253.571 35 17 55 9 55 66 51 7 111 183 1.481 1.501
2025/20261.976 169 81 112 145 83 110 513 116 139 180 220 108
Totale 5.857